Keyphrases
Nasopharyngeal Carcinoma
100%
Nasopharynx
100%
Extramedullary Plasmacytoma
100%
Immuno
22%
Young Males
22%
Male Patients
22%
Collision Tumor
22%
Tumor Cells
11%
Nasal Obstruction
11%
Tumor
11%
Immunoreactivity
11%
CD38
11%
Enlargement
11%
No-report
11%
Differential Diagnosis
11%
Tumor Metastasis
11%
Radiotherapy
11%
Recurrence or Metastasis
11%
Histopathological Features
11%
Unusual Case
11%
Head-and-neck Region
11%
CD79a
11%
CD20
11%
Tumor Recurrence
11%
Malignant Tumor
11%
Nasopharyngeal Mass
11%
Plasmacytoid
11%
Cervical Lymph Node
11%
Right-sided
11%
Second Primary Cancer
11%
Epistaxis
11%
Lymphoplasmacytic
11%
Rare Tumors
11%
Nasopharyngeal
11%
Simultaneous Occurrence
11%
Solitary Mass
11%
MUM1
11%
CD21
11%
CD56
11%
CD138
11%
Irregular Shape
11%
Medicine and Dentistry
Nasopharynx Carcinoma
100%
Nasopharynx
100%
Plasmacytoma
100%
Neoplasm
33%
Immunoglobulin
22%
Malignant Neoplasm
11%
Nasal Congestion
11%
Differential Diagnosis
11%
Radiation Therapy
11%
Metastatic Carcinoma
11%
Tumor Cell
11%
Neck
11%
CD20
11%
Epstein Barr Virus
11%
Tumor Recurrence
11%
Epistaxis
11%
Rare Tumor
11%
Cervical Lymph Node
11%
Second Cancer
11%
Immunoreactivity
11%
Immunology and Microbiology
Nasopharynx
100%
Plasmacytoma
100%
Intravenous Immunoglobulin
25%
Tumor Cell
12%
CD38
12%
Epstein Barr Virus
12%
Immunoreactivity
12%
CD20
12%
Neck
12%
Cervical Lymph Node
12%